Loading company…
NextCure, Inc., based in the US, is a biopharmaceutical company developing immunomedicines for cancers and immune-related diseases.
Founded in 2015 and headquartered in the United States, NextCure, Inc. develops immunomedicines for oncology and immune-related disorders, advancing candidates through clinical trials in North America and Europe. In May 2019 it raised USD 75 mn in an IPO, selling 5 million shares at USD 15 per share on the Nasdaq. The company has completed three deals in total and is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in